Hong Kong Med J 2008;14(Suppl 1):S23-5
A protocol for a multi-centre, double- blinded, randomised, placebo-controlled trial on the efficacy and safety of lopinavir/ritonavir plus ribavirin in the treatment of severe acute respiratory syndrome
WC Yu, ST Lai
Department of Medicine and Geriatrics, Princess Margaret Hospital, 2-10 Princess Margaret Hospital Road, Lai Chi Kok, Kowloon, Hong Kong
 
 
A protocol for a multi-centre, double-blinded, randomised, placebo-controlled trial on the efficacy and safety of lopinavir/ ritonavir plus ribavirin in the treatment of severe acute respiratory syndrome (SARS) was produced. It can be referred to or modified should a future outbreak of SARS occur in Hong Kong.